At that point, a fibrin matrix containing the FN fragments of interest and TG-OVA250–264 was implanted at a distant site at the level of the shoulder girdle close to the brachial lymph nodes or soluble OVA257–264 controls were injected i.d. in the four footpads, and delays in tumor growth were measured. Here, FN1 is linked to neoplasm.